HIGH-AFFINITY NEUROPEPTIDE-Y RECEPTOR ANTAGONISTS

被引:142
作者
DANIELS, AJ [1 ]
MATTHEWS, JE [1 ]
SLEPETIS, RJ [1 ]
JANSEN, M [1 ]
VIVEROS, OH [1 ]
TADEPALLI, A [1 ]
HARRINGTON, W [1 ]
HEYER, D [1 ]
LANDAVAZO, A [1 ]
LEBAN, JJ [1 ]
SPALTENSTEIN, A [1 ]
机构
[1] BURROUGHS WELLCOME CO,DIV ORGAN CHEM,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1073/pnas.92.20.9067
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Neuropeptide Y (NPY) is one of the most abundant peptide transmitters in the mammalian brain. In the periphery it is costored and coreleased with norepinephrine from sympathetic nerve terminals. However, the physiological functions of this peptide remain unclear because of the absence of specific high-affinity receptor antagonists. Three potent NPY receptor antagonists were synthesized and tested for their biological activity in in vitro, ex vivo, and in vivo functional assays. We describe here the effects of these antagonists inhibiting specific radiolabeled NPY binding at Y1 and Y2 receptors and antagonizing the effects of NPY in human erythroleukmia cell intracellular calcium mobilization, perfusion pressure in the isolated rat kidney, and mean arterial blood pressure in anesthetized rats.
引用
收藏
页码:9067 / 9071
页数:5
相关论文
共 24 条
[1]   NEUROPEPTIDE-Y DISTRIBUTION IN HUMAN-BRAIN [J].
ADRIAN, TE ;
ALLEN, JM ;
BLOOM, SR ;
GHATEI, MA ;
ROSSOR, MN ;
ROBERTS, GW ;
CROW, TJ ;
TATEMOTO, K ;
POLAK, JM .
NATURE, 1983, 306 (5943) :584-586
[2]   [D-TRP(32)]NEUROPEPTIDE-Y - A COMPETITIVE ANTAGONIST OF NPY IN RAT HYPOTHALAMUS [J].
BALASUBRAMANIAM, A ;
SHERIFF, S ;
JOHNSON, ME ;
PRABHAKARAN, M ;
HUANG, Y ;
FISCHER, JE ;
CHANCE, WT .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (06) :811-815
[3]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF NEUROPEPTIDE-Y ANALOGS WITH RESPECT TO Y-1 AND Y-2 RECEPTORS [J].
BECKSICKINGER, AG ;
JUNG, G .
BIOPOLYMERS, 1995, 37 (02) :123-142
[4]   NONPEPTIDE PEPTIDOMIMETIC ANTAGONISTS OF THE NEUROPEPTIDE-Y RECEPTOR - BENEXTRAMINE ANALOGS WITH SELECTIVITY FOR THE PERIPHERAL Y-2 RECEPTOR [J].
CHAURASIA, C ;
MISSE, G ;
TESSEL, R ;
DOUGHTY, MB .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (14) :2242-2248
[5]  
DANIELS AJ, 1992, MOL PHARMACOL, V41, P767
[6]  
DANIELS AJ, 1989, BIOCHEM BIOPH RES CO, V187, P1138
[7]  
DANIELS AJ, 1994, Patent No. 9400486
[8]   BENEXTRAMINE NEUROPEPTIDE-Y RECEPTOR INTERACTIONS - CONTRIBUTION OF THE BENZYLIC MOIETIES TO [H-3] NEUROPEPTIDE-Y DISPLACEMENT ACTIVITY [J].
DOUGHTY, MB ;
CHAURASIA, CS ;
LI, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (02) :272-279
[9]   [LEU31,PRO34]NEUROPEPTIDE-Y - A SPECIFIC Y-1 RECEPTOR AGONIST [J].
FUHLENDORFF, J ;
GETHER, U ;
AAKERLUND, L ;
LANGELANDJOHANSEN, N ;
THOGERSEN, H ;
MELBERG, SG ;
OLSEN, UB ;
THASTRUP, O ;
SCHWARTZ, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (01) :182-186
[10]   CHARACTERIZATION OF FUNCTIONAL NEUROPEPTIDE-Y RECEPTORS IN A HUMAN NEUROBLASTOMA CELL-LINE [J].
GORDON, EA ;
KOHOUT, TA ;
FISHMAN, PH .
JOURNAL OF NEUROCHEMISTRY, 1990, 55 (02) :506-513